Cytokine-induced activation of mixed lineage kinase 3 requires TRAF2 and TRAF6

Amanda C Korchnak1, Yu Zhan, Michael T Aguilar

  • 1Department of Biological Sciences, University of Toledo, 2801 West Bancroft Street, MS601, Toledo, OH 43606, USA.

Cellular Signalling
|July 10, 2009
PubMed

Insights

Mixed lineage kinase 3 (MLK3) activation by tumor necrosis factor (TNF) and IL-1 beta involves TRAF2 and TRAF6. Ubiquitination, specifically K63 chains, is crucial for MLK3 kinase activity, while K48 chains target it for degradation.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Immunology

Background:

  • Mixed lineage kinase 3 (MLK3) is a MAP3K activating MAPK pathways in response to stimuli like TNF.
  • MLK3 is essential for TNF-induced SAPK/JNK signaling, but its receptor recruitment and activation mechanisms are unclear.

Purpose of the Study:

  • To elucidate the mechanism of MLK3 activation by TNF and IL-1 beta.
  • To identify the roles of TRAF proteins and ubiquitination in MLK3 regulation.

Main Methods:

  • Stimulation of cells with TNF and IL-1 beta.
  • Co-immunoprecipitation assays to detect protein interactions.
  • RNA interference (RNAi) to knock down TRAF2 and TRAF6.
  • Analysis of MLK3 ubiquitination status.

Main Results:

  • TNF and IL-1 beta rapidly activate MLK3 kinase activity.
  • TNF induced MLK3 interaction with TRAF2; IL-1 beta induced interaction with TRAF6.
  • RNAi knockdown of TRAF2 or TRAF6 impaired MLK3 activation by TNF.
  • TNF stimulated MLK3 ubiquitination with both K48- and K63-linked polyubiquitin chains.

Conclusions:

  • TRAF2 and TRAF6 are critical for MLK3 activation by TNF.
  • K48-linked ubiquitination targets MLK3 for proteasomal degradation.
  • K63-linked ubiquitination is essential for MLK3 kinase activity.
  • This study reveals a novel mechanism for MLK3 activation by pro-inflammatory cytokines.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...